Otofarma SpA (MIL:OTO) Interest Expense: € Mil (TTM As of Dec. 2024)


MIL:OTO Otofarma SpA MIL:OTO
16 GF Score
Price €2.80
! 1 Warning Sign
View Full Analysis

What is Otofarma SpA Interest Expense?

Otofarma SpA MIL:OTO 16 Interest Expense is € Mil as of Dec. 2024. GuruFocus rates MIL:OTO with a GF Score™ of 16/100. The stock has 1 warning sign investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Otofarma SpA's interest expense for the six months ended in Dec. 2024 was € -0.25 Mil. Otofarma SpA does not have enough years/quarters to calculate its interest expense for the trailing twelve months (TTM) ended in Dec. 2024.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Otofarma SpA's Operating Income for the six months ended in Dec. 2024 was € 1.94 Mil. Otofarma SpA's Interest Expense for the six months ended in Dec. 2024 was € -0.25 Mil. Otofarma SpA's Interest Coverage for the quarter that ended in Dec. 2024 was 7.62. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Otofarma SpA  (MIL:OTO) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Otofarma SpA's Interest Expense for the six months ended in Dec. 2024 was €-0.25 Mil. Its Operating Income for the six months ended in Dec. 2024 was €1.94 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2024 was €1.31 Mil.

Otofarma SpA's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Interest Coverage=-1* Operating Income (Q: Dec. 2024 )/Interest Expense (Q: Dec. 2024 )
=-1*1.935/-0.254
=7.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Otofarma SpA Interest Expense Historical Data

* Premium members only.

The historical data trend for Otofarma SpA's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Otofarma SpA Interest Expense Chart

Otofarma SpA Annual Data
Trend Dec23 Dec24
Interest Expense
-0.12 -0.25

Otofarma SpA Semi-Annual Data
Dec23 Dec24
Interest Expense -0.12 -0.25
MIL:OTO
16GF Score
Otofarma SpA MIL:OTO
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Otofarma SpA Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of € Mil mean?
Otofarma SpA (MIL:OTO) has a Interest Expense of € Mil as of Dec. 2024. Interest Expense is the amount a company pays on its long-term debt. View historical data on Otofarma SpA and its competitors.
Is Otofarma SpA's Interest Expense too high?
Otofarma SpA's current Interest Expense is € Mil. Overall, Otofarma SpA has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Otofarma SpA's Interest Expense compare to ABT and SYK?
Otofarma SpA's Interest Expense of € Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Medical Devices & Instruments company?
A good Interest Expense depends on the Medical Devices & Instruments industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Otofarma SpA and its competitors. Otofarma SpA's current Interest Expense is € Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Otofarma SpA stock overvalued right now?
Otofarma SpA (MIL:OTO) has a current Interest Expense of € Mil. The current Interest Expense is € Mil. Otofarma SpA's overall GF Score™ is 16/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Otofarma SpA (MIL:OTO), the current Interest Expense is € Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Otofarma SpA Business Description

Address Ripuaria Way, 50k, Marina di Varcaturo, Naples, ITA, 80014
Otofarma SpA is engaged in the construction and production of hearing aids, is constantly growing in the audiological field to provide adequate responses to every type of hearing aid need to its customers who require the possible personalized application of custom-made hearing aids. It provides otoacoustic medical devices and TELEMEDICINE services exclusively in affiliated pharmacies, possessing a portfolio of Instrumental IT patents.
16GF Score

Get the complete analysis for MIL:OTO

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.80
Price